Anti-osteoporosis agent-4 (Compound 11h) suppresses the differentiation of primary osteoclasts and attenuates RANKL-induced osteoclastogenesis, effectively inhibiting osteoclast formation with an IC50 value of 358.29 nM, and impedes the activation of the PI3K/AKT and IkappaBalpha/NF-kappaB signaling pathways [1].
Molecular Weight:
560.02
Formula:
C26H26ClN3O7S
Target:
NF-kappaB|||PI3K
* VAT and and shipping costs not included. Errors and price changes excepted
